Beauty Health [SKIN] vs Yatsen Holding [YSG] Detailed Stock Comparison
Beauty Health
NASDAQ
Loading...
Yatsen Holding
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Beauty Health wins in 7 metrics, Yatsen Holding wins in 11 metrics, with 0 ties. Yatsen Holding appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Beauty Health | Yatsen Holding | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -8.91 | -1.34 | Beauty Health |
| Price-to-Book Ratio | 3.51 | 0.28 | Yatsen Holding |
| Debt-to-Equity Ratio | 509.08 | 5.71 | Yatsen Holding |
| PEG Ratio | 0.00 | 0.02 | Beauty Health |
| EV/EBITDA | -27.15 | -331.65 | Yatsen Holding |
| Profit Margin (TTM) | -6.13% | -14.10% | Beauty Health |
| Operating Margin (TTM) | -3.45% | -5.11% | Beauty Health |
| Return on Equity | -26.55% | -15.08% | Yatsen Holding |
| Return on Assets (TTM) | -4.45% | -3.15% | Yatsen Holding |
| Free Cash Flow (TTM) | $9.34M | $-42.11M | Beauty Health |
| 1-Year Return | 45.39% | 193.44% | Yatsen Holding |
| Price-to-Sales Ratio (TTM) | 0.84 | 0.24 | Yatsen Holding |
| Enterprise Value | $426.72M | $2.32B | Yatsen Holding |
| EV/Revenue Ratio | 1.38 | 4.42 | Beauty Health |
| Gross Profit Margin (TTM) | 62.81% | 78.25% | Yatsen Holding |
| Revenue per Share (TTM) | $2 | $39 | Yatsen Holding |
| Earnings per Share (Diluted) | $-0.18 | $-0.73 | Beauty Health |
| Beta (Stock Volatility) | 1.23 | -2.11 | Yatsen Holding |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Beauty Health vs Yatsen Holding Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Beauty Health | 1.99% | -1.44% | 24.24% | 28.13% | 58.91% | 27.33% |
| Yatsen Holding | 6.83% | 0.54% | 7.81% | 50.72% | 137.72% | 144.53% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Beauty Health | 45.39% | -83.67% | -79.92% | -79.92% | -79.92% | -79.92% |
| Yatsen Holding | 193.44% | 59.15% | -90.62% | -90.62% | -90.62% | -90.62% |
Performance & Financial Health Analysis: Beauty Health vs Yatsen Holding
| Metric | SKIN | YSG |
|---|---|---|
| Market Information | ||
| Market Cap | $259.99M | $917.37M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 710,960 | 419,760 |
| 90 Day Avg. Volume | 1,146,780 | 477,047 |
| Last Close | $2.05 | $9.39 |
| 52 Week Range | $0.78 - $2.56 | $3.01 - $11.57 |
| % from 52W High | -19.92% | -18.84% |
| All-Time High | $30.17 (Nov 01, 2021) | $127.35 (Feb 08, 2021) |
| % from All-Time High | -93.21% | -92.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.14% | 0.37% |
| Quarterly Earnings Growth | 96.58% | 0.37% |
| Financial Health | ||
| Profit Margin (TTM) | -0.06% | -0.14% |
| Operating Margin (TTM) | -0.03% | -0.05% |
| Return on Equity (TTM) | -0.27% | -0.15% |
| Debt to Equity (MRQ) | 509.08 | 5.71 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.58 | $32.96 |
| Cash per Share (MRQ) | $1.66 | $0.70 |
| Operating Cash Flow (TTM) | $39.43M | $-77,843,406 |
| Levered Free Cash Flow (TTM) | $40.34M | $-99,171,532 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Beauty Health vs Yatsen Holding
| Metric | SKIN | YSG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -8.91 | -1.34 |
| Forward P/E | -12.81 | 134.14 |
| PEG Ratio | 0.00 | 0.02 |
| Price to Sales (TTM) | 0.84 | 0.24 |
| Price to Book (MRQ) | 3.51 | 0.28 |
| Market Capitalization | ||
| Market Capitalization | $259.99M | $917.37M |
| Enterprise Value | $426.72M | $2.32B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.38 | 4.42 |
| Enterprise to EBITDA | -27.15 | -331.65 |
| Risk & Other Metrics | ||
| Beta | 1.23 | -2.11 |
| Book Value per Share (MRQ) | $0.58 | $32.96 |
Financial Statements Comparison: Beauty Health vs Yatsen Holding
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SKIN | YSG |
|---|---|---|
| Revenue/Sales | $78.19M | $152.18M |
| Cost of Goods Sold | $29.08M | $33.10M |
| Gross Profit | $49.11M | $119.09M |
| Research & Development | $1.25M | $5.06M |
| Operating Income (EBIT) | $-2.70M | $-7.77M |
| EBITDA | $24.01M | $-8.54M |
| Pre-Tax Income | $18.72M | $-2.83M |
| Income Tax | $-993,000 | $-106,847 |
| Net Income (Profit) | $19.71M | $-2.73M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SKIN | YSG |
|---|---|---|
| Cash & Equivalents | $373.03M | $133.53M |
| Total Current Assets | $469.37M | $332.51M |
| Total Current Liabilities | $62.80M | $92.21M |
| Long-Term Debt | $562.61M | $18.28M |
| Total Shareholders Equity | $46.06M | $439.56M |
| Retained Earnings | $-518.06M | $-1.13B |
| Property, Plant & Equipment | $13.21M | $34.29M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SKIN | YSG |
|---|---|---|
| Operating Cash Flow | $-577,000 | $-380.19M |
| Capital Expenditures | $-45,000 | $-34.38M |
| Free Cash Flow | $1.85M | $-553.99M |
| Debt Repayment | $0 | $-10.00M |
| Common Stock Repurchase | N/A | $-190.10M |
Short Interest & Institutional Ownership Analysis
| Metric | SKIN | YSG |
|---|---|---|
| Shares Short | 15.47M | 1.76M |
| Short Ratio | 11.39 | 2.97 |
| Short % of Float | 0.27% | 0.06% |
| Average Daily Volume (10 Day) | 710,960 | 419,760 |
| Average Daily Volume (90 Day) | 1,146,780 | 477,047 |
| Shares Outstanding | 124.92M | 257.00M |
| Float Shares | 81.55M | 813.03M |
| % Held by Insiders | 0.10% | 0.04% |
| % Held by Institutions | 0.86% | 0.26% |
Dividend Analysis & Yield Comparison: Beauty Health vs Yatsen Holding
| Metric | SKIN | YSG |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |